Early data from the first population-wide breast cancer-specific registry in Hong Kong.

World J Surg 2012 Apr;36(4):723-9

Hong Kong Breast Cancer Foundation, 22/F, Jupiter Tower, No. 9, Jupiter Street North Point, Hong Kong, China.

Background: Current measures for breast cancer prevention and options for treatment adopted in Hong Kong are mainly based on research data and clinical evidence from overseas. It is essential to establish a cancer-specific registry to monitor the status of breast cancer in Hong Kong.

Objectives: We summarized the current status of breast cancer in Hong Kong based on the data collected from Hong Kong Breast Cancer Registry (HKBCR).

Methods: Prevalent and newly diagnosed breast cancers (including in situ and invasive breast cancers) were registered in the HKBCR. Information on patient demographics, risk factors, medical information, and survival were analyzed and reported in this study.

Results: Data of 2,330 breast cancer patients were analyzed. We observed an earlier median age at diagnosis in Hong Kong than those reported in other countries. Distribution of cancer stage was: stage 0 (11.4%), stage I (31.4%), stage II (41%), stage III (12.5%), stage IV (0.8%), and unclassified (2.9%). The percentages of patients who received surgery, chemotherapy, radiation therapy, and endocrine therapy were 98.7, 67.9, 64.8, and 64.1%, respectively. At a median follow-up of 1.2 years, locoregional recurrence was recorded at 2%, distant recurrence at 2.8%, and breast-cancer-related mortality at 0.3%.

Conclusions: The HKBCR serves as a surveillance program to monitor disease and treatment patterns. It is pivotal to support research for more effective breast cancer prevention and treatment strategies in Hong Kong.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-012-1426-2DOI Listing
April 2012
4 Reads

Publication Analysis

Top Keywords

hong kong
24
breast cancer
24
breast
9
breast cancers
8
status breast
8
cancer hong
8
kong based
8
cancer-specific registry
8
based data
8
cancer prevention
8
cancer
7
hong
7
stage
6
kong
6
314% stage
4
stage 41%
4
stage 314%
4
stage 114%
4
survival analyzed
4
medical survival
4

References

(Supplied by CrossRef)

KJ Carter et al.
Comput Biol Med 2003

International Agency for Cancer Research (IARC) et al.
2008

G Agarwal et al.
World J Surg 2007

EL Kennaway et al.
Br J Cancer 1950

MH Griswold et al.
1955

P Stocks et al.
Bull World Health Org 1959

THC Barclay et al.
1976

Danish Cancer Registry et al.
1985

Similar Publications